Lidocaine 5% patch 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F5W89
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,189
Award facts
- Contract value 100% obligated
- $4,188.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,188.58 to AmerSourceBergen Drug Corp for the supply of Lidocaine 5% Patch in quantities of 30 units. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 12, 2026, and was competitively awarded without a set-aside designation. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order was issued as a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026.
AmerSourceBergen Drug Corp is the operating subsidiary of parent company Cencora, Inc., which holds the master indefinite delivery contract with the Defense Logistics Agency. The company's federal contracting portfolio demonstrates extensive capability in supplying a wide spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs globally. This specific delivery order for topical pain management medication reflects the company's established role as a critical vendor within the DLA's pharmaceutical supply chain, serving Defense Health Agency and other government healthcare systems with essential medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F5W89?
SPE2DR26F5W89 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F5W89 worth?
The government has obligated $4,189 on SPE2DR26F5W89.
Is contract SPE2DR26F5W89 an order under another contract?
Yes. SPE2DR26F5W89 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5W89 competed?
The extent of competition for SPE2DR26F5W89 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award